{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:28:32Z","timestamp":1789939712668,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":1448,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1111\/ajt.14754","type":"journal-article","created":{"date-parts":[[2018,3,31]],"date-time":"2018-03-31T02:25:22Z","timestamp":1522463122000},"page":"2885-2894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"18","author":[{"given":"Jos\u00e9 Luis","family":"Pi\u00f1ana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Perez-Pitarch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Guglieri-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Hernandez-Boluda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Terol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Ferriols-Lisart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Solano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14754_bib1","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1083-8791(03)00287-8","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies","volume":"9","author":"Boeckh","year":"2003","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1111\/ajt.14754_bib2","series-title":"Transplant Infections","first-page":"277","article-title":"Cytomegalovirus infection after hemopoietic stem cell transplantation","author":"Boeckh","year":"2003"},{"issue":"20","key":"10.1111\/ajt.14754_bib3","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood."},{"key":"10.1111\/ajt.14754_bib4","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/S2352-3026(15)00289-6","article-title":"Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study","volume":"3","author":"Green","year":"2016","journal-title":"Lancet Haematol."},{"issue":"11","key":"10.1111\/ajt.14754_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/TP.0b013e31824810e6","article-title":"Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant recipients","volume":"93","author":"Nashan","year":"2012","journal-title":"Transplantation J."},{"issue":"20","key":"10.1111\/ajt.14754_bib6","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1128\/JVI.78.20.11030-11039.2004","article-title":"Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase","volume":"78","author":"Kudchodkar","year":"2004","journal-title":"J Virol."},{"issue":"38","key":"10.1111\/ajt.14754_bib7","doi-asserted-by":"crossref","first-page":"14182","DOI":"10.1073\/pnas.0605825103","article-title":"Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes","volume":"103","author":"Kudchodkar","year":"2006","journal-title":"Proc Natl Acad Sci."},{"issue":"10","key":"10.1111\/ajt.14754_bib8","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1128\/JVI.02733-09","article-title":"Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication","volume":"84","author":"Moorman","year":"2010","journal-title":"J Virol."},{"issue":"6","key":"10.1111\/ajt.14754_bib9","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1111\/j.1600-6143.2012.04002.x","article-title":"CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages","volume":"12","author":"Poglitsch","year":"2012","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.14754_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1182\/blood-2007-01-069294","article-title":"Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis","volume":"2","author":"Marty","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1111\/ajt.14754_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.bbmt.2003.12.305","article-title":"Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation","volume":"10","author":"Cutler","year":"2004","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"10.1111\/ajt.14754_bib12","doi-asserted-by":"crossref","first-page":"e12717","DOI":"10.1111\/tid.12717","article-title":"Impact of cytomegalovirus DNAemia on overall and non-relapse mortality in allogeneic stem cell transplant recipients","volume":"19","author":"Solano","year":"2017","journal-title":"Transpl Infect Dis."},{"issue":"11","key":"10.1111\/ajt.14754_bib13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.3324\/haematol.2016.149294","article-title":"A prospective randomized trial comparing cyclosporine\/methotrexate and tacrolimus\/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation","volume":"101","author":"T\u00f6rl\u00e9n","year":"2016","journal-title":"Haematologica."},{"issue":"8","key":"10.1111\/ajt.14754_bib14","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2014-04-567164","article-title":"Tacrolimus\/sirolimus vs tacrolimus\/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT","volume":"124","author":"Cutler","year":"2014","journal-title":"Blood."},{"key":"10.1111\/ajt.14754_bib15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation","volume":"369","author":"Marty","year":"2013","journal-title":"N Engl J Med."},{"issue":"19","key":"10.1111\/ajt.14754_bib16","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation","volume":"370","author":"Chemaly","year":"2014","journal-title":"N Engl J Med."},{"issue":"11","key":"10.1111\/ajt.14754_bib17","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1182\/blood-2007-11-121558","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study","volume":"111","author":"Winston","year":"2008","journal-title":"Blood."},{"issue":"4","key":"10.1111\/ajt.14754_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(11)70024-X","article-title":"Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial","volume":"11","author":"Marty","year":"2011","journal-title":"Lancet Infect Dis."},{"issue":"4","key":"10.1111\/ajt.14754_bib19","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.transproceed.2013.01.082","article-title":"Maribavir use in practice for cytomegalovirus infection in French transplantation centers","volume":"45","author":"Alain","year":"2013","journal-title":"Transplant Proc."},{"key":"10.1111\/ajt.14754_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/JCM.02571-13","article-title":"Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?","volume":"52","author":"Gim\u00e9nez","year":"2014","journal-title":"J Clin Microbiol."},{"key":"10.1111\/ajt.14754_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/clpt.2009.43","article-title":"Mechanistic modeling of a magnetic marker monitoring study linking gastrointestinal tablet transit, in vivo drug release, and pharmacokinetics","volume":"86","author":"Bergstrand","year":"2009","journal-title":"Clin Pharmacol Ther."},{"issue":"9","key":"10.1111\/ajt.14754_bib22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/psp.2012.9","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling of severity levels of extrapyramidal side effects with markov elements","volume":"1","author":"Pilla","year":"2012","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"issue":"7","key":"10.1111\/ajt.14754_bib23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.bbmt.2017.03.035","article-title":"A time-to-event model for acute kidney injury after reduced-intensity conditioning stem cell transplantation using a tacrolimus- and sirolimus-based graft-versus-host disease prophylaxis","volume":"23","author":"Pi\u00f1ana","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"10.1111\/ajt.14754_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3324\/haematol.2012.065599","article-title":"The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate","volume":"98","author":"Perez-Sim\u00f3n","year":"2013","journal-title":"Haematologica."},{"issue":"15","key":"10.1111\/ajt.14754_bib25","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.clinbiochem.2009.06.018","article-title":"Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer","volume":"42","author":"Schmid","year":"2009","journal-title":"Clin Biochem."},{"key":"10.1111\/ajt.14754_bib26","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/bmt.2015.303","article-title":"Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood","volume":"51","author":"Solano","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1111\/ajt.14754_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.diagmicrobio.2012.10.010","article-title":"Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus CMV DNAemia","volume":"75","author":"Clari","year":"2013","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"1","key":"10.1111\/ajt.14754_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis."},{"key":"10.1111\/ajt.14754_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med."},{"key":"10.1111\/ajt.14754_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc."},{"key":"10.1111\/ajt.14754_bib31","series-title":"NONMEM User\u2019s Guide, NONMEM","author":"Beal","year":"1989"},{"issue":"4","key":"10.1111\/ajt.14754_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00019053-199813040-00003","article-title":"An introduction to Markov modelling for economic evaluation","volume":"13","author":"Briggs","year":"1998","journal-title":"Pharmacoeconomics."},{"issue":"1","key":"10.1111\/ajt.14754_bib33","doi-asserted-by":"crossref","first-page":"e2016031","DOI":"10.4084\/mjhid.2016.031","article-title":"CMV in hematopoietic stem cell transplantation","volume":"8","author":"de la C\u00e1mara","year":"2016","journal-title":"Mediterr J Hematol Infect Dis."},{"key":"10.1111\/ajt.14754_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.chom.2008.03.002","article-title":"Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex","volume":"3","author":"Moorman","year":"2008","journal-title":"Cell Host Microbe."},{"key":"10.1111\/ajt.14754_bib35","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/JVI.02124-06","article-title":"Human cytomegalovirus UL38 protein blocks apoptosis","volume":"81","author":"Terhune","year":"2007","journal-title":"J Virol."},{"key":"10.1111\/ajt.14754_bib36","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1128\/JVI.78.20.11030-11039.2004","article-title":"Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase","volume":"78","author":"Kudchodkar","year":"2004","journal-title":"J Virol."},{"key":"10.1111\/ajt.14754_bib37","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20041851","article-title":"Shared reactivity of VC2neg FC T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells","volume":"201","author":"Halary","year":"2005","journal-title":"J Exp Med."},{"key":"10.1111\/ajt.14754_bib38","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1128\/JVI.02733-09","article-title":"Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication","volume":"84","author":"Moorman","year":"2010","journal-title":"J Virol."},{"key":"10.1111\/ajt.14754_bib39","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1600-6143.2011.03473.x","article-title":"Paradoxical aspects of rapamycin immunobiology in transplantation","volume":"11","author":"Ferrer","year":"2011","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.14754_bib40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08155","article-title":"mTOR regulates memory CD8 T cell differentiation","volume":"460","author":"Araki","year":"2009","journal-title":"Nature."},{"key":"10.1111\/ajt.14754_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00262-010-0945-7","article-title":"Rapamycin increases the yield and effector function of human FC T cells stimulated in vitro","volume":"60","author":"Li","year":"2011","journal-title":"Cancer Immunol Immunother."},{"key":"10.1111\/ajt.14754_bib42","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1172\/JCI5409","article-title":"Implication of FC T cells in the human immune response to cytomegalovirus","volume":"103","author":"De\u2032chanet","year":"1999","journal-title":"J Clin Invest."},{"issue":"7","key":"10.1111\/ajt.14754_bib43","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Li","year":"1994","journal-title":"Blood"},{"issue":"7","key":"10.1111\/ajt.14754_bib44","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbmt.2017.03.027","article-title":"Possible impact of cytomegalovirus-specific CD8 + T cells on immune reconstitution and conversion to complete donor chimerism after allogeneic stem cell transplantation","volume":"23","author":"Ogonek","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"issue":"2","key":"10.1111\/ajt.14754_bib45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbmt.2012.10.006","article-title":"Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis","volume":"19","author":"Shayani","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"issue":"9 suppl","key":"10.1111\/ajt.14754_bib46","first-page":"151S","article-title":"Pharmacometrics 2020","volume":"50","author":"Gobburu","year":"2010","journal-title":"J Clin Pharmacol."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14754","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522098008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522098008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14754\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:22:46Z","timestamp":1761628966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522098008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1600613522098008"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14754","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}